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ABSTRACT
The purpose of malnutrition screening is to predict the prob-
ability of a worse outcome due to nutritional factors. The Malnutri-
tion Universal Screening Tool (MUST) can be used for screening 
in inflammatory bowel disease (IBD); however, it does not provide 
details about body composition. Our aim was to assess the body 
composition and combine this with the MUST method to screen 
risk of malnutrition and sarcopenia. A total of 173 IBD outpatients 
were enrolled in this cross-sectional study. The MUST scale indi-
cated 21.4% of IBD patients to be at risk of malnutrition. A risk 
of sarcopenia was detected in 27.7%. However, one third of these 
patients were not considered to be at risk by their MUST score. Fur-
thermore, Crohn’s disease (CD) patients had a strongly unfavora-
ble fat-free mass index (FFMI) value compared to ulcerative colitis 
(UC) patients, and these differences were significant among men 
(FFMI: 18.62 ± 2.16 vs 19.85 ± 2.22, p = 0.02, in CD and UC 
males, respectively). As sarcopenia is a relevant prognostic factor, 
the MUST method should be expanded to include body composi-
tion analysis to detect more IBD patients at risk of malnutrition and 
sarcopenia in order to start their nutritional therapy immediately.
Key words: Malnutrition screening. Bioelectrical impedance 
analysis. IBD.
INTRODUCTION 
The European Society of Clinical Nutrition and Metab-
olism (ESPEN) defined malnutrition as a state resulting 
from lack of uptake or intake of nutrition leading to altered 
body composition (decreased fat-free mass and body cell 
mass), resulting in diminished physical and mental func-
tion and impaired clinical outcome from disease (1).
Inflammatory bowel disease (IBD) is a chronic, systemic 
autoimmune disease involving chronic inflammation of the 
digestive tract. Reduced nutrition absorption, inadequate 
dietary intake, and chronic inflammation expose the patient 
to catabolic effects. This leads to an increased risk of malnu-
trition, including loss of muscle mass (2,3). Long-standing 
malnutrition may comprise sarcopenia, which is associated 
with decreased chances of survival, worse clinical outcome 
such as increased rate of postoperative infections or com-
plications (4,5), increased toxicity to antitumor therapies in 
gastroenterological malignancies (6,7), and diminished qual-
ity of life in IBD patients (8). The development of sarcopenia 
is a common issue in IBD (9), therefore assessment of the 
nutritional status and screening of sarcopenia risk are impor-
tant parts of IBD patient care. Using a suitable method in the 
appropriate time may help the practitioner screen potentially 
at risk patients at an early stage and introduce individual-
ized nutrition therapy if necessary. The maintenance of an 
adequate nutrition therapy may reduce sarcopenia and it has 
the potential to improve well-being and the disease outcome.
According to current ESPEN Guidelines for Nutrition 
Screening (10), all hospitalized patients should be screened 
regularly for malnutrition with a validated tool (11-14). 
Malnutrition screening offers a simple and rapid process 
conducted by nurses or healthcare teams or patients (as 
self-screening) (15). We used the Malnutrition Universal 
Screening Tool (MUST) questionnaire to screen the risk of 
malnutrition. It is a quick test consisting of three questions: 
actual body mass index (BMI), weight loss, and presence of 
acute disease with regard to the nutritional intake. Although 
it is very simple, its main disadvantage is that it does not 
consider altered body composition. Despite having a nor-
mal BMI and a relatively low chance of being at risk, a 
person can be malnourished if the body fat-muscle ratio is 
abnormal. Patients with a very different distribution of fat 
mass and fat-free mass can have the same BMI value, and 
hence the risk of sarcopenia may not be detected. As the 
ESPEN states, the diagnosis of malnutrition should be based 
on either a low BMI (< 18.5 kg/m2) or the combination of 
weight loss together with either reduced BMI or a low fat 
free mass index (FFMI) (16), whilst sarcopenia is diagnosed 
if low FFMI is associated with a reduction in measured doc-
umented muscle strength or low performance (17).
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There are several methods for measuring body com-
position; dual X-ray absorptiometry (DEXA), computed 
tomography (CT) and bioelectrical impedance analysis 
(BIA) are currently the most frequently used in clinical 
practice. These methods are able to indicate the possible 
tissue loss by distinctly analyzing the two major body com-
ponents: fat-free mass and fat mass. The BIA is based on 
the characteristics of hydrated tissues conducting electric-
ity. The measurement allows the estimation of total body 
water distribution, and thereby assesses body composition 
(18). This easy-to-use method has numerous advantages, 
such as reproducibility and the lack of ionizing radiation, 
and it also enables the monitoring of the effect of nutri-
tional therapy. Our aim was to examine the clinical rel-
evance of the two methods in malnutrition screening at the 
same time. We wanted to determine what proportion of the 
patients potentially at risk we miss when using only the 
MUST questionnaire and, furthermore, if there is any clini-
cal relevance to involve BIA in first line screening process. 
METHODS
Participants
A total of 173 consecutive IBD patients (126 with CD and 47 with 
ulcerative colitis [UC]) were included in the study from September 
until December 2014. 
Participants, who agreed to be included, were over 18 years of 
age and were outpatients of our tertiary IBD center. 
The basic primary inclusion criteria were as follows: the subjects 
were diagnosed with IBD according to the Lennard-Jones criteria (19), 
they were able to adhere to the study protocol (i.e. suitable mobility 
to step up the InBody tool and to hold the hand electrodes), and their 
body mass index was from 16 kg/m2 to 34 kg/m2.
Exclusion criteria were tube or parenteral feeding, extremely low 
or high body mass index (< 16 kg/m2 or > 34 kg/m2), and other 
chronic or malignant diseases. Patients suffering from thyroid or 
other endocrine dysfunction were also excluded from this study. 
Due to the rapid and permanent effects of corticosteroid therapy to 
water and mineral metabolism, steroid dependent patients were also 
excluded from this study. BIA measurement was contraindicated 
for patients with defibrillation, cardiac pacemaker devices, or any 
metal implants. Patients with limb edema or notable ascites were 
also excluded to avoid inaccurate measurement due to water and 
electrolyte imbalances.
Design and data collection
UC and CD were divided into subgroups based on the Montreal 
classification (20). Further disease specific information and physi-
cal characteristics were collected from hospital files and from the 
patients during their visits to our outpatient department. By location, 
UC patients were divided into two groups (pancolitis or left-sided/
distal colitis) based on the last endoscopic findings. Disease activity 
was defined by the partial Mayo score (pMayo) (21). Patients with 
CD were divided into two groups based on whether any small bowel 
involvement was found during the previous endoscopic or imaging 
(CT, magnetic resonance imaging [MRI]). Three categories were 
defined based on CD behavior: inflammatory, stenosing, and penetrat-
ing type. Crohn’s disease activity index (CDAI) and perianal disease 
activity index (PDAI) were used to determine disease activity (22).
To evaluate malnutrition risk, we used MUST according to the 
ESPEN guidelines (10). MUST formulates a risk of malnutrition score 
based on current body mass index (0 points if BMI is > 20 kg/m2; 1 
if BMI is in the range of 18.5-20 kg/m2; 2 if BMI is < 18.5 kg/m2), 
known weight loss (0 points if weight loss is < 5%; 1 if between 
5-10%; 2 if weight loss is > 10%), and the presence of acute disease or 
no nutritional intake for FIVE days (2 points if either of them applies). 
Overall risk of malnutrition is determined from the sum of the points 
as follows: 0 = low risk; 1 = medium risk; and 2-6 = high risk.
Body composition was measured by the InBody 720 body analyz-
er device manufactured by Biospace. InBody 720 uses the segmental 
BIA method to examine the body as five cylinders (four limbs and 
the trunk) and measures impedance in these parts separately. It uses 
electrical currents at various frequencies (1-1,000 kHz) in order to 
measure electrical impedance and to derive the amount of extra- and 
intracellular water content in turn. Each patient was measured when 
fasting, after urination, and undressed except for underwear. All jew-
elry and wristwatches were removed before the measurement. Vari-
ous parameters, including body weight, body mass index (BMI), body 
fat mass (BFM), fat-free mass (FFM), skeletal muscle mass (SMM), 
skeletal lean mass (SLM), total body water (TBW), mineral content, 
and body cell mass (BCM) were automatically calculated. According 
to the ESPEN recommendations, FFM and BFM were calculated for 
all participants and their respective indices were compared against 
reference data (23). Analogous to BMI, these indices were calculated 
as body composition parameters given in kg divided by the height 
in square meters; this transformation facilitates the interpretation of 
body composition variables regardless of height (24). 
Sarcopenia can be considered as “primary” (or age-related) when 
no other cause is evident except for ageing itself, while it can be 
considered as “secondary” when one or more other causes are evi-
dent. In connection with IBD, we focused on secondary sarcopenia. 
According to the ESPEN recommendations, we defined the risk of 
sarcopenia when the fat-free mass was low, defined by FFMI ≤ 17 kg/
m2 for men and ≤ 15 kg/m2 for women (16,25). As our study did 
not include a handgrip measurement to detect muscle function, we 
only detected a reduction of FFMI, which is called pre-sarcopenia, 
considered to be a potentially at risk state.
Ethical considerations
The study was approved by the Semmelweis University Regional 
and Institutional Committee of Science and Research Ethics Com-
mittee (TUKEB number: 255/2013), and it was performed in accord-
ance with the Declaration of Helsinki. Every patient matching the 
inclusion criteria agreed to participate and gave informed consent.
Data analysis
For our calculations the SPSS statistics v22.0 software was used. 
Paired and independent sample Student’s t-tests and Pearson’s cor-
relations were applied. One-way analysis of variance (ANOVA) was 
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performed for the comparison of means of continuous variables and 
normally distributed data; categorical variables were assessed by a 
Chi-squared or Fisher’s exact test. Concordance between MUST and 
body composition metric data (FFMI and BMI) was calculated by 
analysis of variance, as MUST was categorical, whilst the body com-
position was a numerical variable. Cohen’s kappa was also calculated 
with categorical variables based on the level of FFMI risk categories. 
The vertical part of the established 2x2 contingency table showed if 
a patient was at risk of low FFMI, while the horizontal part showed 
MUST risk.
Results are shown as mean ± standard deviation (SD). The level 
of significance was p < 0.05.
RESULTS
A total of 173 IBD patients were included in the study; 
126 (72.8%) of them suffered from CD, while 47 (27.2%) 
were UC patients. Mean age was 34.8 ± 12.3 years. Major 
anthropometrical values were similar in the two patient 
groups (Table I).
MUST indicated 37 (21.4%) while BIA (considering 
FFMI) indicated 48 (27.8%) patients to have alarmingly 
low parameters (Table II and Fig. 1). When comparing the 
body composition results in different MUST groups, we 
found that 11 (9.3%) patients in the MUST-based low-risk-
of-malnutrition group had alarmingly low FFMI values, 
thus indicating a risk of sarcopenia (Fig. 2).
According to the concordance analyses, we found a 
modest relationship between MUST and BIA methods 
(with metrics data: BMI = 33.5% [p < 0.0001], FFMI = 
29.2% [p < 0.0001]; categorical variables: Cohen’s kappa 
= 0.53 [95% CI: 0.39-0.67]). We observed that 12.1% of 
all patients had a low MUST risk, while they were already 
malnourished based on FFMI. 
In our study 92 (53.2%) patients were male and 81 
(46.8%) were female. We found no difference between the 
rate of being underweight or at risk of being malnourished 
among genders either in BMI or in MUST scores. Among 
women, there was no significant difference between the 
mean of BIA parameters in CD vs UC patients, whilst men 
Table II. Proportion of patients in different MUST  
and BIA group
All patients UC patients CD patients
MUST
(n [%])
MUST low 118 (68.2%) 35 (74.5%) 83 (65.9%)
MUST medium 18 (10.4%) 3 (6.4%) 15 (11.9%)
MUST high 37 (21.4%) 9 (19.1%) 28 (22.2%)
BIA
(n [%]) 
FFMI low 48 (27.7%) 11 (23.4%) 37 (29.4%)
BFMI low 26 (15.0%) 5 (10.6%) 21 (16.7%)
BIA: Bioelectrical impedance analyzer; BFMI: Body fat mass index; CD: Crohn’s 
disease; MUST: Malnutrition Universal Screening Tool; UC: Ulcerative colitis.
Table I. Patients characteristic
All patients UC (n = 47) CD (n = 126)
Age (years) 34.8 ± 12.3 38.3 ± 13.6 33.5 ± 11.5
Height (cm) 172.0 ± 9.4 170.3 ± 10.0 172.6 ± 9.1
Weight (kg) 70.0 ± 16.6 72.7 ± 17.5 69.0 ± 16.2
Duration (months) 108.6 ± 96.4 100.1 ± 95.6 111.9 ± 96.8
Gender: male/female (%) 53.2/46.8 51.1/48.9 54.1/46.0
BMI (kg/m2) 23.6 ± 5.2 24.9 ± 5.2 23.1 ± 5.1
Ulcerative colitis (n [%])
Location
Left sided
Pancolitis
16 (34.0%)
31 (6.0%)
Disease activity
Mild or inactive
Moderate
Severe
23 (48.9%)
16 (34.1%)
8 (17.0%)
Crohn’s disease (n [%])
Disease type
Inflammatory
Stenosing
Penetrating
78 (61.9%)
14 (11.1%)
34 (27.0%)
Disease activity
Mild or Inactive
Moderate
Severe
96 (76.2%)
26 (20.6%)
4 (3.2%)
Disease location
L1 Terminal Ileum 
L2 Colonic 
L3 Ileocolon 
L4 Upper gastrointestinal 
5 (4.0%) 
42 (33.3%)
70 (55.6%)
9 (7.1%) 
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suffering from CD had a significantly lower body composi-
tion index than men with UC (Table III).
BMI of CD patients differed significantly compared to 
UC patients (23.12 ± 5.11 vs 24.98 ± 5.20, p = 0.036, 
respectively). However, no significant differences were 
found in the number of patients categorized into different 
groups based on the MUST scale (Table II). CD patients 
had tendentiously lower scores in body composition 
parameters compared to UC patients (Table III).
Among UC patients, we found that the rate of malnutri-
tion risk was 19.1% (n = 9), and an even higher proportion 
of at risk patients were detected by low FFMI based on 
body composition analysis 23.4% (n = 11). Measured body 
composition parameters were evaluated in subgroup analy-
ses by the extensiveness of the disease and actual activity. 
According to our findings, the extent of the disease did 
not affect the body composition results significantly. We 
observed a weak positive correlation between the disease 
activity defined by pMayo score and FFMI (r = -0.316).
Among CD patients, the rate of being at risk of malnu-
trition was found to be 22.2% (n = 28) calculating MUST 
scores and 29.4% (n = 37) based on FFMI. Location, 
type, and disease activity were examined in a subgroup 
analysis. A higher proportion of small bowel involvement 
CD patients were underweighted by BMI than those with 
colonic disease (14.3% vs 4.0%), and they had more unfa-
vorable body composition results as well. Small bowel 
involvement seems to be a potential risk factor in CD 
as significant differences were found in FFMI (16.91 ± 
2.41 vs 18.24 ± 2.56, p = 0.05) and body fat mass index 
(BFMI, 5.08 ± 2.93 vs 7.15 ± 4.91, p = 0.004), respec-
tively. However, the ratio of MUST low, medium, and high 
risks did not differ significantly between these two groups: 
the corresponding percentages were 61.9%, 14.3%, and 
23.8% in low bowel involvement, and 73.8%, 7.1%, and 
19.0% in colon involvement, respectively. Malnutrition 
risk and main BIA parameters were compared in patients 
with inflammatory, stenosing, and penetrating type of CD. 
None of them showed any statistically significant differ-
ences according to the disease behavior. However, patients 
with the stenosing type (n = 14) showed the worst nutri-
tional status according to FFMI (42.9%, n = 6), or highest 
risk according to the MUST scale (57.1%, n = 8). No sig-
nificant difference was observed regarding body composi-
tion parameters between patients with mild or moderate 
disease. Neither the duration of the disease nor the actual 
Table III. Body composition parameters
All patients UC CD p (UC vs CD)
Fat-free mass index (kg/m2) 17.55 ± 2.66 18.09 ± 2.93 17.36 ± 2.54 NS
 FFMI female 15.97 ± 2.19 16.24 ± 2.41 15.86±2.11 NS
 FFMI male 18.95 ± 2.23 19.85 ± 2.22 18.62 ± 2.16 0.020
Body fat mass index (kg/m2) 6.08 ± 3.77 6.89 ± 3.53 5.77 ± 3.82 NS
 BFMI female 7.41 ± 4.13 7.91 ± 3.79 7.22 ± 4.27 NS
 BFMI male 4.89 ± 2.96 5.91 ± 3.01 4.53 ± 2.29 0.05
Body fat percent (%) 24.14 ± 10.39 26.37 ± 9.68 23.30 ± 10.55 NS
Visceral fat area (cm2) 99.28 ± 54.51 105.95 ± 58.38 96.79 ± 53.02 NS
BIA: bioelectrical impedance analyzer; BFMI: Body fat mass index; CD: Crohn’s disease; MUST: Malnutrition Universal Screening Tool; UC: Ulcerative colitis.
Fig. 1. Patients at risk based on MUST and BIA data.
Fig. 2. Altered FFMI among patients in the low MUST group and in the 
normal BMI group.
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disease severity correlated with the body composition 
parameters.
DISCUSSION
Appropriate assessment and follow-up of the nutritional 
status of IBD patients have gained more attention recently, 
but there is a lack of data regarding the suitable methods. 
Weight measurement based methods and questionnaires 
like MUST can be an important step in the screening of 
malnutrition risk. Low FFMI value was also defined by 
the ESPEN as a marker of risk of being malnourished, as 
not only body weight changes, but also altered body com-
position is a potential risk factor for worst outcome of the 
disease, and poorer quality of life in chronic disorders. In 
fact, even with an apparently normal BMI body composi-
tion can be altered.
Numerous diagnostic methods have been introduced to 
measure nutritional status. Based on the definition of mal-
nutrition, its identification requires methods that simulta-
neously measure FFM and BFM. DEXA is a reproducible 
reference method for the clinical practice, although it has 
a high cost, X-ray exposition, low accessibility, a need 
for trained operators, and it cannot be performed at the 
bedside. CT can assess FFM by regional analysis of the 
third lumbar vertebra. The difficulties in this technique 
are similar to DEXA’s. In contrast, BIA is an easy-to-
use, non-invasive, relatively inexpensive method, which 
does not use ionizing radiation. A limitation of the BIA 
method is that it is not accurate during dehydration or 
over-hydration (26). For patients in the reproductive age 
group, as the significant majority of IBD patients are, 
a method without ionizing radiation should be the first 
choice in our opinion.
Nutritional status of IBD patients is particularly relevant 
as these patients are potentially at risk of malnutrition. 
Symptoms of acute disease (such as diarrhea, malabsorp-
tion, and decreased dietary intake) and the presence of 
chronic inflammation may lead to malnutrition and altered 
body composition as well. Bryan et al. recently reviewed the 
corresponding literature comparing the body composition of 
IBD patients and healthy controls (27). However, the num-
ber of patients was relatively low in the studies included; 
besides, the methodology of the measurements was hetero-
geneous as they used different DEXA and BIA instruments. 
Data of IBD patients (631 CD and 295 UC patients) were 
analyzed in this review. Statistically significant reduction in 
BMI was reported in 37% of CD and 20% of UC patients; 
reduced FFMI in 28% of CD and 13% of UC patients. Val-
entini et al. compared 144 IBD patients’ nutritional status 
and body composition. They found most patients (74%) to 
be well nourished according to the subjective global assess-
ment and BMI; however, body composition analysis dem-
onstrated a decrease in body cell mass (28).
According to our results, the rates of patients at risk 
defined by the MUST score and by FFMI from the BIA 
measurements were notably different: while MUST indi-
cated a risk of malnutrition for about 1/5 of our patients 
(21.4%), BIA indicated a potential risk of sarcopenia for 
more than 1/4 of them (27.7%). Our findings suggest that 
BMI-based questionnaires like MUST might miss a valu-
able proportion of IBD patients at risk of malnutrition. 
Body weight and changes in weight are still the main pil-
lars of the MUST calculation, but they do not carry enough 
information about the composition of the body. According 
to our findings, 23.5% of the patients who were in the nor-
mal BMI range had alarmingly low FFMI, and a further 
9.3% of the patients had decreased FFMI although being 
categorized to have low risk of malnutrition by the MUST 
scale. These results indicate that without BIA measurement 
we would miss nearly a quarter of the patients with normal 
BMI and every 10th patient in the low MUST category, 
although they are at risk of sarcopenia.
Fig. 3. Contribution of patients based on BMI and FFMI. A. Female. 
B. Male. The X-axis and Y-axis cut-point was chosen based on the risk 
level of MUST and BIA parameters.
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When combining the MUST and BIA methods, we 
found that 12.1% of the patients that had relatively low 
MUST scores already had altered body composition. 
These results are not surprising as MUST was not cre-
ated to replace body composition measurement. How-
ever, our study seems to confirm and emphasize that the 
BIA method would have an adequate role in the primary 
screening process. By measuring FFMI, we may identify 
more patients with poor nutritional status, and it may 
also indicate the possibility of sarcopenia as the major 
risk factor for unfavorable clinical outcomes in chronic 
diseases. The results also warn us not to fall into the trap 
of just measuring body composition of patients at risk by 
MUST. Otherwise we would miss a relatively high pro-
portion of patients who already should have nutritional 
support. Early diagnosis allows the establishment of a 
proper and individual nutritional plan under the control 
of a dietician. Nutritional therapy should be introduced 
forth with if the patient is deemed to be at risk from 
malnutrition questionnaires or if low FFMI (< 15 kg/m2 
for females, < 17 kg/m2 for men) is detected (16). Moni-
toring body composition regularly helps to personalize 
nutritional plans and reduce the risk of malnutrition and 
sarcopenia, resulting in a better quality of life for our 
patients (29). IBD patients therapy needs a multidisci-
plinary approach and individually tailored diagnostic and 
therapeutic decisions at the same time. Combined use of 
MUST and BIA allows the dietician and the gastroen-
terologist to comply with all these principles. Although 
the examined population was fairly heterogeneous, the 
results of the subgroup analyses reveal the importance 
of body composition analyses of the vulnerable part of 
IBD patients. CD patients showed a higher risk of being 
malnourished than UC patients, furthermore stenosing 
CD type seemed to be a potential risk factor, as these 
patients possessed tendentiously worse body composition 
parameters. The findings suggest that CD patients, espe-
cially those with the stenosing type, need greater atten-
tion in the clinical practice. A significant difference was 
found in body composition parameters between patients 
categorized into different MUST categories in our study. 
These data indicate that MUST provides a reliable screen-
ing function for clinical use. However, its sole use might 
pose a risk of underdiagnosing the rate of unfavorable 
nutritional status in IBD patients. Furthermore, the most 
important limitation of the exclusive use of MUST as 
a screening tool is that it is not suitable for monitoring 
nutrition therapy. As all aspects of IBD patient care are 
leading towards personalized medicine, we believe that 
BIA could be a reasonable method to evaluate the risk of 
malnutrition, as well as to diagnose the risk of sarcopenia. 
In the future, there may be a need to define also age 
and disease-specific, percentile-based thresholds, which 
can simplify the practitioner’s screening tasks (30). In our 
view, malnutrition screening by MUST should be extended 
with body composition analysis by BIA, especially in IBD 
patients. We suggest combining them in patients suffering 
from IBD.
Limitations of the study
A limitation of our study is the relatively heterogene-
ous population and low number of cases in the subgroup 
analysis. Further studies should increase the number of 
participants to have far-reaching clinical implications. 
Although our study was conducted in a referral center for 
IBD, our outpatient population is quite diverse and comes 
from different parts of the country. We acknowledge that 
it may not be as representative as a multicenter survey.
CONCLUSIONS
According to our findings, the MUST scale is an optional 
and recommended part of outpatient care, and it is a useful 
tool to screen for the risk of malnutrition. However, it still 
does not provide sufficient information to select and follow 
the potentially at risk IBD patients in outpatient care. Body 
composition analysis, like BIA, should be implemented along 
with MUST in the clinical practice to optimize screening.
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